Author: Ammren
FDA mollify concerns over AstraZeneca Covid-19 vaccine safety in Ghana
The Food and Drugs Authority (FDA) has reaffirmed its commitment to monitoring the safety of all vaccines used in Ghana, including COVID-19 vaccines. The FDA says that the Emergency Use Authorization (EUA) for AstraZeneca vaccines which expired in May 2023, coincided with the World Health Organization listing COVID-19 as no […]
New dengue vaccine TAK-003 gains WHO prequalification for high-burden areas
A new vaccine for dengue received prequalification from the World Health Organization (WHO) on 10 May 2024. TAK-003 is the second dengue vaccine to be prequalified by WHO. Developed by Takeda, it is a live-attenuated vaccine containing weakened versions of the four serotypes of the virus that cause dengue. WHO […]